Virtual screening workflow development guided by the "receiver operating characteristic" curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4.
By N. Triballeau, F. Acher, I. Brabet, J. Pin, H. Bertrand. 2005
555 citations recorded by the source corpus.
Subfields: Cellular and Molecular Neuroscience, Computational Theory and Mathematics, Molecular Biology
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cellular and Molecular Neuroscience
In Computational Theory and Mathematics
- F. Silva-Jr
- Paula Jofily
- Shota Uehara
- Shigenori Tanaka
- I. Kapetanovic
- Pedro H. M. Torres
- A. C. Sodero
In Molecular Biology
- F. Silva-Jr
- Paula Jofily
- Shota Uehara
- Shigenori Tanaka
- I. Kapetanovic
- Pedro H. M. Torres
- A. C. Sodero
Citations in the corpus
- Key Topics in Molecular Docking for Drug Design (2019, background): “The calculations are made based on cut-offs throughout the whole rank, and therefore ROC reflects only overall performance [100,101].”
- Comparison of Several Molecular Docking Programs: Pose Prediction and Virtual Screening Accuracy (2009, background): “16,71,76 This metric can be used to effectively differentiate between two populations, so it is suited for evaluating virtual screening performance where one needs to discriminate between active and decoy compounds.”
- Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach. (2008, methodology): “The “receiver operating characteristic (ROC)” curves have also been used as a metric to evaluate the ability of virtual screening in discriminating between active and inactive compounds [44,45].”
- AutoDock-GIST: Incorporating Thermodynamics of Active-Site Water into Scoring Function for Accurate Protein-Ligand Docking (2016, methodology): “At last, the performance of virtual screening was evaluated by area under the curve (AUC) of receiver operating characteristic (ROC) [84] and enrichment factor (EF) [85].”